Blog
This competition showcases posters and a brief video created by early career healthcare professionals from across the country on six areas of liver educational focus.
American Liver Foundation mourns the loss of Col. Stephen A. Harrison, MD, FACP, FAASLD, a revered leader in the field of hepatology, specifically in fatty liver disease (now called steatotic liver disease).
American Liver Foundation grateful to our Congressional Champions and Advocates
Today, American Liver Foundation mourns the passing of a leader on Capitol Hill, the Honorable Donald Payne, Jr, (D-NJ).
After his father passed away from liver cancer in 1999, Jim made it his mission to raise public awareness of liver disease and raise funds for liver disease research by running marathons in his memory. This year, as Jim approaches his 300th marathon, he has challenged himself to raise $100,000 for ALF. Read about Jim's legendary mission and how he hopes to change the face of liver disease one step at a time.
The American Liver Foundation (ALF) is proud to once again be a member of the Boston Marathon Official Charity Program for the 2024 Boston Marathon®, which takes place on Monday, April 15, 2024.
Thousands join together to support the nearly 100 million Americans affected by liver disease.
ALF has teamed up with world-renowned culinary chefs for FLAVORS, a national culinary event to be held in Phoenix, Arizona on May 22, 2024.
After nearly losing her life to alcohol use disorder and alcohol-associated liver disease, Beth has dedicated her second chance to honoring the gift of life she received. Learn more about Beth’s inspiring story and how she is helping to eliminate stigma and break down barriers to organ donation.
April is Donate Life Month and ALF has new patient resources, programs and support available to all liver transplant patients and the caregivers supporting them.
On behalf of the entire American Liver Foundation family, we express our deepest condolences to the family of our former board member, Robert Merowitz, who recently passed away.
First drug therapy treatment for nonalcoholic steatohepatitis (NASH) provides hopes to millions of Americans